Brief: Epigenomics Says Microsimulation Model Demonstrates Positive Results For Epi Procolon(R) Blood Test
07/01/2019 06:47
Jan 7 (Reuters) - EPIGENOMICS AG ECXn.DE :
* SAYS MICROSIMULATION MODEL WAS COMPLETED BY EXTERNAL
ACADEMIC
EXPERTS DEMONSTRATING POSITIVE RESULTS FOR EPI PROCOLON(R) BLOOD
TEST
Source text for Eikon: ID:nEQbdcXdWa
Further company coverage: ECXn.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns